Skip to content
>
⌘K
⌘/
Start free
☾
Research
▾
Screener
SCR
·
Filing search
SRCH
·
Compare
CMP
·
Expectations
EXP
Markets
▾
Market
MOST
·
Sectors
SECT
·
World
WEI
·
Macro
ECO
·
Maturity wall
DDIS
·
Correlation
CORR
Portfolio
▾
Portfolio
PORT
·
Builder
PRTM
Tools
▾
Graph
G
·
Score
RANK
·
Workspace
WS
Smart money
▾
Managers
MGR
·
Best Ideas
IDEA
·
Congress
CG
·
Executive
EXEC
·
Shorts
SHRT
·
Insiders
INSD
·
Analysts
RATE
Events & estimates
▾
Events
EVX
·
Calendar
CAL
·
Biotech
BIOT
·
Terminal events
DLST
Yours
▾
Watchlist
WL
·
Alerts
ALRT
·
Filing changes
FDIG
·
Saved
MY
Special Topics
▾
AI Infrastructure
Defense
Quantum
All studies →
Screener
Portfolio
Managers
Watchlist
More
NMRA US Equity
☆
Neumora Therapeutics, Inc.
Nasdaq
+ Compare
Tear sheet →
Health Care
· Biological Products, (No Diagnostic Substances) · CIK 1885522 · FY ends Dec 31
$1.52
-0.13 (-7.62%)
USD · as of 2026-08-20 · marketstack
Switch Ticker
DES
Overview
GP
Chart
FA
Financials
FS
Strength
FV
Fair Value
RV
Relative Value
EARN
Earnings
ANR
Ratings
EVTS
Events
TRLS
Trials
OWN
Ownership
SI
Short Interest
RSK
Risk
?
Help
🔒
Altman Z, Piotroski F, Beneish M and the growth-durability CAGRs are part of our derived engine — Pro on every name.
Unlock everything with Pro — $29.99/mo
·
See it live on AAPL →
Related →
Screen every stock on these scores (EQS)
Build your own composite score (SCORE)
Financials (FA)
Earnings-quality methodology
